UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT

The Lancet (British edition), 1997-03, Vol.349 (9053), p.667-674

1997

Volltextzugriff (PDF)

Depressed Heart rate variability identifies postinfarction patients who might benefit from prophylactic treatment with amiodarone : A substudy of EMIAT (The European Myocardial Infarct amiodarone trial)

Journal of the American College of Cardiology, 2000-04, Vol.35 (5), p.1263-1275

2000

Volltextzugriff (PDF)

Identification of post acute myocardial infarction patients with potential benefit from prophylactic treatment with amiodarone. A substudy of EMIAT (the European Myocardial Infarct Amiodarone Trial)

European heart journal, 1998, Vol.19 (1), p.85-95

1998

Volltextzugriff (PDF)

The Irbesartan in Heart Failure With Preserved Systolic Function (I-PRESERVE) Trial: Rationale and Design

Journal of cardiac failure, 2005-10, Vol.11 (8), p.576-585

2005

Volltextzugriff (PDF)

Blockade of Angiotensin II Type 1 Receptors: Effect on Carotid and Radial Artery Structure and Function in Hypertensive Humans

Journal of vascular research, 2000-01, Vol.37 (1), p.8-15

2000

Volltextzugriff (PDF)

Amiodarone interaction with β-blockers : Analysis of the merged EMIAT (European Myocardial Infarct Amiodarone Trial) and CAMIAT (Canadian Amiodarone Myocardial Infarction Trial) databases

Circulation (New York, N.Y.), 1999-05, Vol.99 (17), p.2268-2275

1999

Volltextzugriff (PDF)

The European Myocardial Infarct Amiodarone Trial (EMIAT)

The American journal of cardiology, 1993-11, Vol.72 (16), p.F95-F98

1993

Volltextzugriff (PDF)

Rationale and design of ACTIVE: The atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events

The American heart journal, 2006-06, Vol.151 (6), p.1187-1193

2006

Volltextzugriff (PDF)

Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials

The Lancet (British edition), 1997-11, Vol.350 (9089), p.1417-1424

1997

Volltextzugriff (PDF)

Does amiodarone reduce sudden death and cardiac mortality after myocardial infarction?

European heart journal, 1994-05, Vol.15 (5), p.620-624

1994

Volltextzugriff (PDF)

Effects of repetitive administration of growth hormone-releasing hormone on growth hormone secretion, insulin-like growth factor I, and bone metabolism in postmenopausal women

Acta endocrinologica (Copenhagen), 1989-01, Vol.120 (1), p.121-128

1989

Volltextzugriff (PDF)

Assessment of the value of wavelet analysis of Holter recordings for the prediction of sudden cardiac death

Computers in Cardiology 2001. Vol.28 (Cat. No.01CH37287), 2001, p.81-84

2001

Volltextzugriff (PDF)

A placebo-controlled trial of intranasal growth hormone-releasing hormone [GHRH(1-44)-NH2] administration in normal young adults

Hormone research, 1990, Vol.33 (1), p.1-4

1990

Volltextzugriff (PDF)

Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators

The Lancet (British edition), 1997-03, Vol.349 (9053), p.667-674

1997

Volltextzugriff (PDF)

Oral teriflunomide added to interferon-beta in patients with relapsing multiple sclerosis: 1-year safety and efficacy results

MULTIPLE SCLEROSIS JOURNAL, 2010, Vol.16 (8), p.996

2010

Volltextzugriff (PDF)

THE EFFECTS OF INTRAVENOUS(IV), SUBCUTANEOUS (SC) AND INTRANASAL (IN) ADMINISTRATION OF 6H-RH(1–44)MH2 ON GROWTH-HORMONE SECRETION IN NORMAL MEN: DOSE-RESPONSE RELATIONSHIPS

Pediatric research, 1988-01, Vol.23 (1), p.120-120

1988

Volltextzugriff (PDF)

Irbesartan in patients with type 2 diabetes mellitus and microalbuminuria (IRMA II): Design and baseline characteristics

DIABETOLOGIA, 2001, Vol.44, p.A275

2001

Volltextzugriff (PDF)

The European Myocardial Infarct Amiodarone Trial (EMIAT). EMIAT Investigators

The American journal of cardiology, 1993-11, Vol.72 (16), p.95F-98F

1993

Volltextzugriff (PDF)

Dose-effect study of intranasal administration of growth hormone-releasing hormone-44-NH2 in healthy subjects

The journal of clinical endocrinology and metabolism, 1990-08, Vol.71 (2), p.512-515

1990

Volltextzugriff (PDF)

Does amiodarone reduce sudden death and cardiac mortality after myocardial infarction ? The European Myocardial Infarct Amiodarone Trial (EMIAT)

European heart journal, 1994-05, Vol.15 (5), p.620-624

1994

Volltextzugriff (PDF)

Amiodarone interaction with beta-blockers: analysis of the merged EMIAT (European Myocardial Infarct Amiodarone Trial) and CAMIAT (Canadian Amiodarone Myocardial Infarction Trial) databases. The EMIAT and CAMIAT Investigators

Circulation (New York, N.Y.), 1999-05, Vol.99 (17), p.2268

1999

Volltextzugriff (PDF)

EP-1327: Positioning and interfraction movement in stereotactic body radiation for lung cancer

Radiotherapy and oncology, 2013-03, Vol.106, p.S500-S500

2013

Volltextzugriff (PDF)

PO-0968 INTERFRACTION REPRODUCIBILTY OF PRONE BREAST RADIO-THERAPY: AN UPDATE

Radiotherapy and oncology, 2012-05, Vol.103, p.S381-S382

2012

Volltextzugriff (PDF)

Depressed heart rate variability identifies postinfarction patients who might benefit from prophylactic treatment with amiodarone

Journal of the American College of Cardiology, 2000-04, Vol.35 (5), p.1263-1275

2000

Volltextzugriff (PDF)

Synthesis of 17α-(Iodovinyl)estradiol and Analogous Derivatives by Iododestannylation of Insoluble Polymer-Supported Organotin Precursors

European journal of organic chemistry, 1999-04, Vol.1999 (4), p.781-783

1999

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(35)
Tagungsberichte
(4)

Sprache

Erscheinungsjahr

n.n

Thema

Biological And Medical Sciences
(15)
Science & Technology
(15)
Life Sciences & Biomedicine
(14)
Medical Sciences
(14)
Humans
(12)
Male
(12)
Pharmacology. Drug Treatments
(12)
Female
(11)
Middle Aged
(9)
Cardiovascular System
(8)
Cardiovascular System & Cardiology
(8)
Aged
(7)
Cardiac & Cardiovascular Systems
(7)
Adult
(6)
Amiodarone - Therapeutic Use
(6)
Antiarythmic Agents
(6)
Animals
(4)
Anti-Arrhythmia Agents - Therapeutic Use
(4)
Double-Blind Method
(4)
Drug Therapy
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT

Depressed Heart rate variability identifies postinfarction patients who might benefit from prophylactic treatment with amiodarone : A substudy of EMIAT (The European Myocardial Infarct amiodarone trial)

Identification of post acute myocardial infarction patients with potential benefit from prophylactic treatment with amiodarone. A substudy of EMIAT (the European Myocardial Infarct Amiodarone Trial)

The Irbesartan in Heart Failure With Preserved Systolic Function (I-PRESERVE) Trial: Rationale and Design

Blockade of Angiotensin II Type 1 Receptors: Effect on Carotid and Radial Artery Structure and Function in Hypertensive Humans

Amiodarone interaction with β-blockers : Analysis of the merged EMIAT (European Myocardial Infarct Amiodarone Trial) and CAMIAT (Canadian Amiodarone Myocardial Infarction Trial) databases

The European Myocardial Infarct Amiodarone Trial (EMIAT)

Rationale and design of ACTIVE: The atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events

Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials

Does amiodarone reduce sudden death and cardiac mortality after myocardial infarction?

Effects of repetitive administration of growth hormone-releasing hormone on growth hormone secretion, insulin-like growth factor I, and bone metabolism in postmenopausal women

Assessment of the value of wavelet analysis of Holter recordings for the prediction of sudden cardiac death

A placebo-controlled trial of intranasal growth hormone-releasing hormone [GHRH(1-44)-NH2] administration in normal young adults

Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators

Oral teriflunomide added to interferon-beta in patients with relapsing multiple sclerosis: 1-year safety and efficacy results

THE EFFECTS OF INTRAVENOUS(IV), SUBCUTANEOUS (SC) AND INTRANASAL (IN) ADMINISTRATION OF 6H-RH(1–44)MH2 ON GROWTH-HORMONE SECRETION IN NORMAL MEN: DOSE-RESPONSE RELATIONSHIPS

Irbesartan in patients with type 2 diabetes mellitus and microalbuminuria (IRMA II): Design and baseline characteristics

The European Myocardial Infarct Amiodarone Trial (EMIAT). EMIAT Investigators

Dose-effect study of intranasal administration of growth hormone-releasing hormone-44-NH2 in healthy subjects

Does amiodarone reduce sudden death and cardiac mortality after myocardial infarction ? The European Myocardial Infarct Amiodarone Trial (EMIAT)

Amiodarone interaction with beta-blockers: analysis of the merged EMIAT (European Myocardial Infarct Amiodarone Trial) and CAMIAT (Canadian Amiodarone Myocardial Infarction Trial) databases. The EMIAT and CAMIAT Investigators

EP-1327: Positioning and interfraction movement in stereotactic body radiation for lung cancer

PO-0968 INTERFRACTION REPRODUCIBILTY OF PRONE BREAST RADIO-THERAPY: AN UPDATE

Depressed heart rate variability identifies postinfarction patients who might benefit from prophylactic treatment with amiodarone

Synthesis of 17α-(Iodovinyl)estradiol and Analogous Derivatives by Iododestannylation of Insoluble Polymer-Supported Organotin Precursors

Suchergebnisse filtern